202 related articles for article (PubMed ID: 30078801)
21. Enhancers and super-enhancers have an equivalent regulatory role in embryonic stem cells through regulation of single or multiple genes.
Moorthy SD; Davidson S; Shchuka VM; Singh G; Malek-Gilani N; Langroudi L; Martchenko A; So V; Macpherson NN; Mitchell JA
Genome Res; 2017 Feb; 27(2):246-258. PubMed ID: 27895109
[TBL] [Abstract][Full Text] [Related]
22. Ikaros tumor suppressor function includes induction of active enhancers and super-enhancers along with pioneering activity.
Ding Y; Zhang B; Payne JL; Song C; Ge Z; Gowda C; Iyer S; Dhanyamraju PK; Dorsam G; Reeves ME; Desai D; Huang S; Payne KJ; Yue F; Dovat S
Leukemia; 2019 Nov; 33(11):2720-2731. PubMed ID: 31073152
[TBL] [Abstract][Full Text] [Related]
23. Super-Enhancers Dysregulations in Hematological Malignancies.
Belloucif Y; Lobry C
Cells; 2022 Jan; 11(2):. PubMed ID: 35053311
[TBL] [Abstract][Full Text] [Related]
24. S1P-S1PR3-RAS promotes the progression of S1PR3
Zhu D; Jiang T; Ma D; Zhang H; Zhang J; Lv W; Gong M; Wang H; Liu Z; Su H; Zeng L; Liu S; Tang S; Yang B; Tshavuka FI; Fu G; Liu Z; Peng D; Liu H; Yan Z; Cao Z; Zhao H; He TC; Yu J; Shu Y; Zou L
Leukemia; 2023 Oct; 37(10):1982-1993. PubMed ID: 37591940
[TBL] [Abstract][Full Text] [Related]
25. Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs.
Hah N; Benner C; Chong LW; Yu RT; Downes M; Evans RM
Proc Natl Acad Sci U S A; 2015 Jan; 112(3):E297-302. PubMed ID: 25564661
[TBL] [Abstract][Full Text] [Related]
26. Regulatory network analysis reveals the oncogenesis roles of feed-forward loops and therapeutic target in T-cell acute lymphoblastic leukemia.
Xia M; Zhang Q; Luo M; Li P; Wang Y; Lei Q; Guo AY
BMC Med Genomics; 2019 Jan; 12(1):8. PubMed ID: 30646895
[TBL] [Abstract][Full Text] [Related]
27. Harnessing the MYB-dependent TAL1 5'super-enhancer for targeted therapy in T-ALL.
Smith C; Touzart A; Simonin M; Tran-Quang C; Hypolite G; Latiri M; Andrieu GP; Balducci E; Dourthe MÉ; Goyal A; Huguet F; Petit A; Ifrah N; Baruchel A; Dombret H; Macintyre E; Plass C; Ghysdael J; Boissel N; Asnafi V
Mol Cancer; 2023 Jan; 22(1):12. PubMed ID: 36650499
[TBL] [Abstract][Full Text] [Related]
28. Proposal of a genetic classifier for risk group stratification in pediatric T-cell lymphoblastic lymphoma reveals differences from adult T-cell lymphoblastic leukemia.
Balbach ST; Makarova O; Bonn BR; Zimmermann M; Rohde M; Oschlies I; Klapper W; Rössig C; Burkhardt B
Leukemia; 2016 Apr; 30(4):970-3. PubMed ID: 26216196
[No Abstract] [Full Text] [Related]
29. [ Super-enhancers. Are they regulators of regulatory genes of development and cancer?].
Didych DA; Tyulkina DV; Pleshkan VV; Alekseenko IV; Sverdlov ED
Mol Biol (Mosk); 2015; 49(6):915-22. PubMed ID: 26710770
[TBL] [Abstract][Full Text] [Related]
30. Requirement for TP73 and genetic alterations originating from its intragenic super-enhancer in adult T-cell leukemia.
Ong JZL; Yokomori R; Wong RWJ; Tan TK; Ueda R; Ishida T; Iida S; Sanda T
Leukemia; 2022 Sep; 36(9):2293-2305. PubMed ID: 35908104
[TBL] [Abstract][Full Text] [Related]
31. Repressed BMP signaling reactivates NKL homeobox gene MSX1 in a T-ALL subset.
Nagel S; Ehrentraut S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
Leuk Lymphoma; 2015 Feb; 56(2):480-91. PubMed ID: 24844359
[TBL] [Abstract][Full Text] [Related]
32. Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia.
Kloetgen A; Thandapani P; Ntziachristos P; Ghebrechristos Y; Nomikou S; Lazaris C; Chen X; Hu H; Bakogianni S; Wang J; Fu Y; Boccalatte F; Zhong H; Paietta E; Trimarchi T; Zhu Y; Van Vlierberghe P; Inghirami GG; Lionnet T; Aifantis I; Tsirigos A
Nat Genet; 2020 Apr; 52(4):388-400. PubMed ID: 32203470
[TBL] [Abstract][Full Text] [Related]
33. Helix-loop-helix (E2-5, HEB, TAL1 and Id1) protein interaction with the TCRalphadelta enhancers.
Bernard M; Delabesse E; Smit L; Millien C; Kirsch IR; Strominger JL; Macintyre EA
Int Immunol; 1998 Oct; 10(10):1539-49. PubMed ID: 9796921
[TBL] [Abstract][Full Text] [Related]
34. microRNAs regulate TAL1 expression in T-cell acute lymphoblastic leukemia.
Correia NC; Melão A; Póvoa V; Sarmento L; Gómez de Cedrón M; Malumbres M; Enguita FJ; Barata JT
Oncotarget; 2016 Feb; 7(7):8268-81. PubMed ID: 26882564
[TBL] [Abstract][Full Text] [Related]
35. UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia.
Benyoucef A; Palii CG; Wang C; Porter CJ; Chu A; Dai F; Tremblay V; Rakopoulos P; Singh K; Huang S; Pflumio F; Hébert J; Couture JF; Perkins TJ; Ge K; Dilworth FJ; Brand M
Genes Dev; 2016 Mar; 30(5):508-21. PubMed ID: 26944678
[TBL] [Abstract][Full Text] [Related]
36. RUNX1 promotes cell growth in human T-cell acute lymphoblastic leukemia by transcriptional regulation of key target genes.
Jenkins CE; Gusscott S; Wong RJ; Shevchuk OO; Rana G; Giambra V; Tyshchenko K; Islam R; Hirst M; Weng AP
Exp Hematol; 2018 Aug; 64():84-96. PubMed ID: 29733873
[TBL] [Abstract][Full Text] [Related]
37. A novel LSD1 inhibitor NCD38 ameliorates MDS-related leukemia with complex karyotype by attenuating leukemia programs via activating super-enhancers.
Sugino N; Kawahara M; Tatsumi G; Kanai A; Matsui H; Yamamoto R; Nagai Y; Fujii S; Shimazu Y; Hishizawa M; Inaba T; Andoh A; Suzuki T; Takaori-Kondo A
Leukemia; 2017 Nov; 31(11):2303-2314. PubMed ID: 28210006
[TBL] [Abstract][Full Text] [Related]
38. Super-enhancers are transcriptionally more active and cell type-specific than stretch enhancers.
Khan A; Mathelier A; Zhang X
Epigenetics; 2018; 13(9):910-922. PubMed ID: 30169995
[TBL] [Abstract][Full Text] [Related]
39. RUNX1 colludes with NOTCH1 to reprogram chromatin in T cell acute lymphoblastic leukemia.
Islam R; Jenkins CE; Cao Q; Wong J; Bilenky M; Carles A; Moksa M; Weng AP; Hirst M
iScience; 2023 Jun; 26(6):106795. PubMed ID: 37213235
[TBL] [Abstract][Full Text] [Related]
40. A Tumor Suppressor Enhancer of
Tottone L; Lancho O; Loh JW; Singh A; Kimura S; Roels J; Kuchmiy A; Strubbe S; Lawlor MA; da Silva-Diz V; Luo S; Gachet S; García-Prieto CA; Hagelaar R; Esteller M; Meijerink JPP; Soulier J; Taghon T; Van Vlierberghe P; Mullighan CG; Khiabanian H; Rocha PP; Herranz D
Blood Cancer Discov; 2021 Jan; 2(1):92-109. PubMed ID: 33458694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
